- cafead   Mar 13, 2024 at 11:02: AM
via Ionis Pharmaceuticals (IONS.O), opens new tab said on Wednesday its experimental drug to treat a type of fatty liver disease met the main goal of reducing inflammation of the critical organ in a mid-stage trial.
article source
article source